机译:Safety and Outcomes in Infants Born to Mothers Participating in Retosiban Treatment Trials: ARIOS Follow-up Study
Pharma Research & Development, GlaxoSmithKline, Research Triangle Park, North Carolina;
Department of Obstetrics and Gynecology, University of Texas Medical Branch, University of Texas;
Barts and the London School of Medicine and Dentistry, Queen Mary University of LondonEpidemiology, GlaxoSmithKline, Stockley ParkGlaxoSmithKlinePharma Research & Development, GlaxoSmithKlineDepartamento de Pediatría, Facultad de Medicina, Universidad Autónoma de Nuevo León, Nuevo LeónClinical Development, GlaxoSmithKline, Stockley Park;
retosiban; preterm birth; oxytocin receptor antagonists; neurodevelopment;